COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.
Eisai, Inc. - Exhibitor


 

 

 

 

 

 

https://us.eisai.com/en

Contact Information:

Kim Kelley
Cell:  763-232-2475
kim_kelley@eisai.com

Amy Flynn Brennan
Cell: 320-249-1677
amyflynn_brennan@eisai.com

Zoom Information with available hours

ZOOM LINK

Meeting ID: 977 1735 9404
Passcode: 217497

Available during all exhibit hall times, breaks, and before and after the program each day.

Virtual Exhibit Hall Home

 

At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.

Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.